Contrast issues in brain tumor imaging. Neuroimaging Clin N Am 1999 Nov;9(4):733-49
Date
10/13/1999Pubmed ID
10517942Scopus ID
2-s2.0-0032702288 (requires institutional sign-in at Scopus site) 12 CitationsAbstract
The utility of gadolinium-based MR imaging contrast agents and iodinated CT contrast agents is discussed in the context of brain tumor imaging. Although contrast materials are routinely administered for brain tumor imaging to improve lesion conspicuity and characterization, the optimal dose and imaging protocols vary according to lesion type and location, the specific clinical situation, and the imaging equipment that is available. Special problems may be encountered in contrast-enhanced imaging of patients with brain tumors who have undergone treatment with surgery, radiation, or chemotherapy.
Author List
Abdullah ND, Mathews VPAuthor
Vincent Mathews MD Chair, Professor in the Radiology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Brain NeoplasmsContrast Media
Humans
Magnetic Resonance Imaging
Tomography, X-Ray Computed